Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filing Details

Document Details

Filing Date
Feb 14, 2019
Document Date
Feb 14, 2019
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
electroCore
Issuer
ElectroCore, LL